Understanding FDA's 2026 Clinical Decision Support Guidance: It's Not Deregulation
The FDA’s January 2026 CDS guidance isn’t deregulation, it’s smart, risk-based clarity. AI tools that support physician judgment without black-box automation can move faster. High-risk diagnostic systems remain regulated. That’s not stepping back, it’s focusing oversight where it truly matters.